Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
93 hedge funds and large institutions have $664M invested in Icosavax, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 9 closing their positions.
322% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 9
101% more capital invested
Capital invested by funds: $331M → $664M (+$333M)
100% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 15
45% more funds holding
Funds holding: 64 → 93 (+29)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
88% less call options, than puts
Call options by funds: $830K | Put options by funds: $7.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$28.9M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$14M |
| 3 |
WIC
Water Island Capital
New York
|
+$8.44M |
| 4 |
BlackRock
New York
|
+$5.64M |
| 5 |
SCM
Segantii Capital Management
Hong Kong
|
+$4.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.9M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$23.7M |
| 3 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$16.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$9.2M |
ICVX Hedge Fund Activity: Q4 2023 in Review
93 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q4 2023, worth a combined $664M — up 101% from $331M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ICVX positions and 9 closed out — a net gain of 29 holders — while 30 added to existing stakes and 15 trimmed.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $28.9M. The largest seller was Fidelity Investments, cutting an estimated $30.9M.
- 93 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q4 2023, up from 64 in Q3 2023.
- Funds reported $664M of Icosavax, Inc. Common Stock stock for Q4 2023, up 101% quarter-over-quarter.
- 38 funds opened new Icosavax, Inc. Common Stock positions in Q4 2023 and 9 closed out, a net change of +29 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q4 2023 was Pentwater Capital Management, an estimated $28.9M added.
- The largest Icosavax, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $30.9M sold.
Based on aggregated 13F filings for Q4 2023.